ReviewBioanalysis2025

Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins.

Makoto Niwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.